Poland· PL-100097597
Nifuroksazyd Hasco
A nifuroxazide product containing nifuroxazidum, registered in Poland by Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.. The same ATC class is registered in 3 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Nifuroxazide is registered in 3 of 19 countries.
Countries holding a registration under ATC A07AX03 (nifuroxazide), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Nifuroxazide · ATC A07AX03
3 / 19 countries
- Czechiaprice
- Germany
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Nifuroxazidum
- Manufacturer
- Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
- Country
- Poland (PL)
- ATC code
- A07AX03
- ATC class
- Nifuroxazide
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990834617
- gtin05909990834624
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nifuroxazide in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Bulgaria · Нифуроксазид Алкалоид-Инт
- Czechia · Ercefuryl
- Germany · Pentofuryl
- Greece · Diarine, Nifuroxazide Lavipharm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b18df8fe-df4a-4bcc-88b6-99279beb6ef5 GET /v1/drugs/b18df8fe-df4a-4bcc-88b6-99279beb6ef5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zawiesina doustna",
"source": "urpl",
"strength": "220 mg/5 ml",
"packaging": "05909990834617 ¦ Rp ¦ 16369\n1 butelka 100 g\n05909990834624 ¦ Rp ¦ Skasowane ¦ 18696\n1 butelka 90 ml",
"substance": "Nifuroxazidum 220 mg/5 ml",
"common_name": "Nifuroxazidum",
"pl_product_id": "100097597",
"pozwolenie_nr": "08346",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about nifuroxazide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.